loading page

Challenges in lung cancer diagnosis during the outbreak of COVID-19
  • +1
  • chunhua xu,
  • wei wang,
  • li li,
  • jiwang wang
chunhua xu
Author Profile
jiwang wang
Author Profile

Abstract

A pandemic of 2019 novel coronavirus diseases (COVID-19) outbreak is a major public health emergency that has spread in the fastest speed, and caused the most extensive infection world widely. Transbronchial biopsy (TBB) and computed tomography guided percutaneous needle biopsy (CTPNB) is the most common and significant method for the diagnosis of lung cancer. During the COVID-19 pandemic, the indications of TBB and CTPNB must be managed strictly. Therefore, it is extremely indispensable to perform meticulous and individualized management for lung cancer patients to protect the patients from COVID-19.

Peer review status:UNDER REVIEW

13 Nov 2020Submitted to International Journal of Clinical Practice
20 Nov 2020Assigned to Editor
20 Nov 2020Submission Checks Completed
21 Nov 2020Reviewer(s) Assigned